Standardized 25-Hydroxyvitamin D Measurements in Parkinson's Disease Patients With COVID-19.

Speeckaert, Marijn M; Speeckaert, Reinhart; Delanghe, Joris R

Speeckaert, Marijn M; Speeckaert, Reinhart; Delanghe, Joris R.

Speeckaert MM; Department of Nephrology, Ghent University Hospital, Ghent, Belgium.
Speeckaert R; Research Foundation-Flanders (FWO), Brussels, Belgium.
Delanghe JR; Department of Dermatology, Ghent University Hospital, Ghent, Belgium.

Mov Disord ; 35(9): 1497, 2020 09.

Article in English | MEDLINE | ID: covidwho-757840

Subject(s)

COVID-19; Parkinson Disease; Vitamin D Deficiency; Humans; Italy; Parkinson Disease/complications; SARS-CoV-2; Vitamin D/analogs & derivatives; Vitamin D Deficiency/complications

Keywords

COVID19; Parkinson's disease; standardization; vitamin D

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Parkinson Disease / Vitamin D Deficiency / COVID-19 Topics: Long Covid Limits: Humans Country/Region as subject: Europa Language: English Journal: Mov Disord Journal subject: Neurology Year: 2020 Document Type: Article Affiliation country: Mds.28213

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google